Published Date: 13 Mar 2023
This document outlines goals for improving the quality of care in nursing homes and provides recommendations to support these efforts.
Read Full NewsModelling shows fewer cases and deaths with screening starting at age 45 years.
A phase 3 trial examines whether carfilzomib-lenalidomide-dexamethasone maintenance therapy improves disease control compared with lenalidomide alone in patients with multiple myeloma.
Although many surgeons avoid it, nipple-sparing mastectomy after radiation is a feasible alternative to skin-sparing mastectomy and may help preserve patients’ psychological well-being.
1.
Immunotherapy Combo Active in Advanced PD-L1-Negative HNSCC
2.
Quads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma
3.
Inadvertent lung cancer screening results are discussed in a new study.
4.
Which Salvage Therapy Is Best for Recurrent Prostate Cancer?
5.
Thriving while surviving: Understanding the social needs of cancer survivors
1.
Innovative Marketing Strategies for Oncology Drugs: A Clinician’s Take on Digital and B2B Trends
2.
Precision Medicine and Genomics: Harnessing Longitudinal Data Modeling to Decode Cancer Progression
3.
Revolutionizing Cancer Treatment: The Promise of Bevacizumab Injections
4.
Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
5.
The Latest Research on Wiskott Aldrich Syndrome
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VII
3.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV
4.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part III
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation